Unique ID issued by UMIN | UMIN000039375 |
---|---|
Receipt number | R000044422 |
Scientific Title | Guided Internet-based cognitive behavioral therapy for obsessive-compulsive disorder: a randomized comparison / assessment blind test |
Date of disclosure of the study information | 2020/02/03 |
Last modified on | 2022/02/03 16:54:30 |
Guided Internet-based cognitive behavioral therapy for obsessive-compulsive disorder: a randomized comparison / assessment blind test
Guided ICBT for OCD: a randomized comparison / assessment blind test
Guided Internet-based cognitive behavioral therapy for obsessive-compulsive disorder: a randomized comparison / assessment blind test
Guided ICBT for OCD: a randomized comparison / assessment blind test
Japan |
Obsessive-compulsive disorder
Psychiatry |
Others
NO
To examine effectiveness of Guided Internet-based cognitive behavioral therapy for patients with obsessive-compulsive disorder
Safety,Efficacy
Confirmatory
Not applicable
Yale-Brown Obsessive-Compulsive Scale
Obsessive-Compulsive Inventory
Working Alliance Inventory-Short Form
EuroQol-5-Devison
Patient Health Questionnaire-9
Generalized Anxiety Disorder-7
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
NO
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Educational,Counseling,Training
Device,equipment | Behavior,custom |
Guided internet cognitive behavioral therapy
Usual care
15 | years-old | <= |
60 | years-old | >= |
Male and Female
Inclusion criteria for this study include being between 18 and 60 years old, having a primary diagnosis of OCD according to the Mini-International Neuropsychiatric Interview (M.I.N.I.) with the initially diagnosed OCD patients remaining symptomatic, having OCD that is at least moderate or higher in severity with a Yale-Brown Obsessive-Compulsive score of > 14, having skills to send e-mail, and having access to the e-learning system.
Participants with any of the following conditions will be excluded: psychosis, organic mental disorder, current high risk of suicide, substance abuse or dependence within the 12 months prior to enrollment, antisocial personality disorder, or unstable medical condition.
30
1st name | Eiji |
Middle name | |
Last name | Shimizu |
Chiba University
Research Center for Child Mental Development
260-8677
1-8-1 Inohana, Chuouku, Chiba, Japan
043-226-2027
eiji@faculty.chiba-u.jp
1st name | Kazuki |
Middle name | |
Last name | Matsumoto |
Chiba University
Research center for child mental development
260-8677
1-8-1, Inohana, Chuouku, Chiba, Japan
043-226-2975
axpa0219@chiba-u.jp
Research Center for Child Metnal Development, Chiba University
Japan society for the promotion of science
Japanese Governmental office
University of Fukui
Chiba University
Research center for child mental development
0432262616
prc-jim@chiba-u.jp
NO
千葉大学医学部附属病院(千葉県)、福井大学医学部附属病院(福井県)
2020 | Year | 02 | Month | 03 | Day |
https://www.researchprotocols.org/2020/6/e18216
Unpublished
31
Completed
2019 | Year | 11 | Month | 20 | Day |
2019 | Year | 11 | Month | 20 | Day |
2020 | Year | 01 | Month | 06 | Day |
2021 | Year | 03 | Month | 31 | Day |
As of July 31, 2020, 9 cases have been registered. Of these, 4 have completed the intervention or a waiting priod, and 5 are on the clinical trial. There are no reports of any adverse events at this time.
2020 | Year | 02 | Month | 03 | Day |
2022 | Year | 02 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044422